Webinar:Trends and Innovations Emerging from Israel's Pharmaceutical and Healthcare Ecosystem-July 6

TradeIL Korea hosted the webinar "Trends and Innovations Emerging from Israel's Pharmaceutical and Healthcare Ecosystem," featuring leading Israeli biotech and healthcare companies showcasing how AI is transforming the future of pharmaceuticals and healthcare. The webinar opened with welcome remarks by Ms. Tamar Kosher Maron, Head of TradeIL Korea, followed by a keynote from Aion Labs on AI-driven healthcare innovation. Company presentations from CytoReason, Protai, and Scopio Labs highlighted breakthroughs in AI-powered disease modeling, proteomics-based drug discovery, and digital cell morphology. The event brought together participants from leading Korean pharmaceutical and biotech companies, hospitals, venture capital firms, law firms, and APAC TradeIL offices, including Australia, Hong Kong, and Singapore, highlighting growing interest in Korea-Israel collaboration. 05:52 Ms. Tamar Kosher Maron, Head of TradeIL Korea 06:57 Mr. Mati Gill, CEO, Aion Labs 26:38 Mr. Tal Almog, Senior Account Program Manager, CytoReason 39:46 Mr. Eran Seger, CEO & Co-founder, Protai 55:48 Mr. Amir Farhi, CCO, Scopio Labs To learn more about the featured Israeli companies or explore collaboration opportunities, please contact us at [email protected]